Navigation Links
ROXRO PHARMA Marks 5th Year Of Cafe Scientifique Sponsorship
Date:4/16/2008

Thousands Have Participated in Wide Range of Scientific Discussions Since

ROXRO Organized Area's First Cafe Scientifique in 2004

MENLO PARK, Calif., April 16 /PRNewswire/ -- ROXRO PHARMA, Inc. today announced the continuation of its sponsorship of Cafe Scientifique Silicon Valley (http://www.cafescisv.org), an innovative concept that brings together scientists and the general public in a cafe environment for discussions on diverse scientific topics ranging from stem cells to global warming to genetically engineered foods.

"We are pleased to continue to support this innovative forum that brings cutting-edge and topical science to members of our community," said Roger Whiting, ROXRO PHARMA President and Chief Scientific Officer. "Cafe Scientifique has had remarkable success since we began the first cafe on the West Coast in 2004," he said.

The world's first Cafe Scientifique was held in 1998 in England and spawned a grassroots movement that has taken hold in hundreds of cities on every continent around the globe. The informal events are held in a variety of venues worldwide including bars, theaters, churches and other community gathering places.

Locally, ROXRO has been instrumental in organizing the participation of scientific and technology experts and in ensuring a very broad range of topics for discussion. Attendance at the monthly gatherings in Silicon Valley has risen steadily from about 50 initially to over 200 participants, requiring a move to larger quarters provided by SRI International at its headquarters in Menlo Park. "We are pleased to support Cafe Scientifique Silicon Valley and provide a space that accommodates the large number of participants while maintaining the informal cafe environment so essential to an open sharing of ideas and opinions," said Walter Moos, vice president of SRI's Bioscience Division.

"Cafe Scientifique is a place where anyone can come to learn about the latest ideas in science and technology in plain language," Whiting said. "We've had talks as diverse as gravitation and aging, saving whales, the chemistry of chocolate and nanotechnology. Our goal in organizing these monthly events is to make current scientific issues more accessible to the general public while making scientists more accountable to the public at large."

All Cafe Scientifique events are free and open to the public. Events are held at SRI's International Building at 333 Ravenswood Ave., Menlo Park. For more information on Cafe Scientifique Silicon Valley activities, go to http://www.cafescisv.org.

ABOUT ROXRO PHARMACEUTICALS

ROXRO PHARMA, Inc., of Menlo Park, is a privately owned specialty pharmaceutical company focused on the treatment of pain. Founded in 1999, Roxro in-licenses promising drug candidates for rapid development in acute pain conditions. The company's highly experienced management team engages a global network of experts to conduct pre-clinical and clinical studies and to manufacture drug products. This year Roxro plans to submit an application to the U.S. Food and Drug Administration seeking approval to market its lead compound, ROX-888, for the treatment of moderate-to-severe post-operative pain. For more information on Roxro, go to http://www.roxropharma.com.


'/>"/>
SOURCE ROXRO PHARMA, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries
2. Brandes Proposes 130 yen per Share Dividend and 10 Million Share Buyback Program for Ono Pharmaceutical Annual Meeting
3. AWWA Urges Science-Based Approach in Addressing Pharmaceutical Compounds in Water
4. Simcere Pharmaceutical Group to Announce First Quarter 2008 Earnings on Tuesday, May 6, 2008
5. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
6. Pharmacyclics Announces Conference Call to Discuss Third Quarter 2008 Financial Results
7. Alexion Pharmaceuticals Invites You to Participate in its First Quarter 2008 Results Conference Call and Web Cast
8. Qforma Unveils Managed Care Optimization Solution for Pharma Marketing Executives
9. U.S. Pharmacopeia Aiding FDA in Improved Tests for Heparin Contamination
10. ApothecaryRx Provides Exit Strategy for Boomer Pharmacy Businesses; Sustains Service and Communication Structure of Community Pharmacies to Improve Drug Compliance, Reduce Drug Errors
11. NCPA Declares April 14 - 18 Protect Your Pharmacy Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College ... nursing professionals advance their careers. Beginning in the fall of 2017, Emmanuel’s program will ... in as few as 16 months and for as little as $14,528. These changes ...
(Date:4/24/2017)... ... 24, 2017 , ... Michael Vick announced his retirement earlier this year from ... overall number one pick in the 2001 NFL Draft, to the Atlanta Falcons, made ... the most career rushing yards by a quarterback (6,109) and the most rushing yards ...
(Date:4/24/2017)... Lake City, UT (PRWEB) , ... April 24, 2017 , ... ... their efforts to encourage sustainability, innovate new strategies to reduce waste, and support renewable ... herbal remedy provider. They look to nature to find solutions for health issues, and ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director ... Communication of Education Research Award. The award honors scholars exemplary in their capacity ... a scholar who has demonstrated the capacity to deepen the public’s understanding and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)... BOSTON , April 19, 2017  New research provides ... with advanced Parkinson,s, according to a study released today that ... 69th Annual Meeting in Boston , ... comes to the treatment of Parkinson,s disease, the oral drug ... of life and longevity. But as the disease progresses, the ...
Breaking Medicine Technology: